|

Oncomine™ combines a rapidly growing compendium of 41,000+ expertly curated cancer genomic profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates target discovery and validation and supports the prioritization of tumor populations for drug development.
Oncomine was developed by physicians, scientists, and software engineers at the University of Michigan and is now fully supported for the commercial and non-profit research community by Compendia Bioscience.
Oncomine Concepts Edition is a powerful web application that integrates and unifies high-throughput cancer profiling data so that target expression across a large volume of cancer types, subtypes, and experiments can be assessed online, in seconds. Additionally, it allows users to search the Oncomine database for enrichment of user-defined gene signatures. These analyses provide valuable insight into biology, regulation, pathways, drug response, and patient populations.
Oncomine Research Edition is a powerful web application that integrates and unifies high-throughput cancer profiling data so that target expression across a large volume of cancer types, subtypes, and experiments can be assessed online, in seconds.
This edition based on the original Oncomine product provided by the University of Michigan to the academic community. It remains under a free license for non-commercial users pursuing non-commercial purposes.
|